symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
SXTC,3.19,0.726112,217181,33323378,0,2.335-24.5,0.31,"China SXT Pharmaceuticals, Inc.",USD,0001723980,VGG2161P1080,G2161P108,NASDAQ Capital Market,NASDAQ,Drug Manufacturersâ€”Specialty & Generic,https://www.sxtchina.com,"China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.",Mr. Feng  Zhou,Healthcare,CN,88,86 523 8629 8290,178 North Taidong Road,Taizhou,,225300,0.926485,1.96649,https://financialmodelingprep.com/image-stock/SXTC.png,2019-01-04,False,False,True,False,False
